BACKGROUND: Polymerase chain reaction (PCR) allows detection of Trypanosoma cruzi in blood throughout the course of Chagas' disease. OBJECTIVE: To determine whether T cruzi DNA detected by PCR is associated with progression to chronic Chagas cardiomyopathy. DESIGN: Prospective cohort study. SETTING: A tertiary care centre in Argentina. PATIENTS: 56 consecutive patients with chronic T cruzi infection. METHODS: Clinical examination, ECG, and Doppler echocardiography were carried out at baseline and at the end of the follow up. Detection of T cruzi DNA by PCR amplifying a nuclear sequence was undertaken in all patients at baseline. MAIN OUTCOME MEASURES: Progression was defined as death from chronic cardiomyopathy or the presence of a new ECG or left ventricular echocardiographic abnormality at the end of follow up. RESULTS: The 56 patients (21 male, 35 female; mean (SD) age, 56.0 (11.3) years) were followed for a mean 936.3 (244.39) days. Progression to cardiomyopathy was detected in 12 patients (21.4%). Three of these patients died after baseline evaluation. Univariate analysis showed that a positive PCR (relative risk 4.09, 95% confidence interval (CI) 1.60 to 9.85) and male sex (5.00, 95% CI 1.65 to 15.73) were associated with progression. Multivariable logistic regression indicated that both sex and PCR were independent variables affecting the outcome. CONCLUSIONS: In a cohort of seropositive individuals, patients with T cruzi DNA detected by PCR and male patients were at higher risk of progression. These results highlight the importance of T cruzi in the pathophysiology of chronic cardiomyopathy.
BACKGROUND: Polymerase chain reaction (PCR) allows detection of Trypanosoma cruzi in blood throughout the course of Chagas' disease. OBJECTIVE: To determine whether T cruzi DNA detected by PCR is associated with progression to chronic Chagas cardiomyopathy. DESIGN: Prospective cohort study. SETTING: A tertiary care centre in Argentina. PATIENTS: 56 consecutive patients with chronic T cruzi infection. METHODS: Clinical examination, ECG, and Doppler echocardiography were carried out at baseline and at the end of the follow up. Detection of T cruzi DNA by PCR amplifying a nuclear sequence was undertaken in all patients at baseline. MAIN OUTCOME MEASURES: Progression was defined as death from chronic cardiomyopathy or the presence of a new ECG or left ventricular echocardiographic abnormality at the end of follow up. RESULTS: The 56 patients (21 male, 35 female; mean (SD) age, 56.0 (11.3) years) were followed for a mean 936.3 (244.39) days. Progression to cardiomyopathy was detected in 12 patients (21.4%). Three of these patients died after baseline evaluation. Univariate analysis showed that a positive PCR (relative risk 4.09, 95% confidence interval (CI) 1.60 to 9.85) and male sex (5.00, 95% CI 1.65 to 15.73) were associated with progression. Multivariable logistic regression indicated that both sex and PCR were independent variables affecting the outcome. CONCLUSIONS: In a cohort of seropositive individuals, patients with T cruzi DNA detected by PCR and male patients were at higher risk of progression. These results highlight the importance of T cruzi in the pathophysiology of chronic cardiomyopathy.
Authors: O A Salomone; D Juri; M O Omelianiuk; A Sembaj; A M Aguerri; C Carriazo; J M Barral; R Madoery Journal: Am J Cardiol Date: 2000-05-15 Impact factor: 2.778
Authors: C Britto; C Silveira; M A Cardoso; P Marques; A Luquetti; V Macêdo; O Fernandes Journal: Mem Inst Oswaldo Cruz Date: 2001-08 Impact factor: 2.743
Authors: A Riarte; C Luna; R Sabatiello; A Sinagra; R Schiavelli; A De Rissio; E Maiolo; M M Garcìa; N Jacob; M Pattin; M Lauricella; E L Segura; M Vázquez Journal: Clin Infect Dis Date: 1999-09 Impact factor: 9.079
Authors: N Añez; H Carrasco; H Parada; G Crisante; A Rojas; C Fuenmayor; N Gonzalez; G Percoco; R Borges; P Guevara; J L Ramirez Journal: Am J Trop Med Hyg Date: 1999-05 Impact factor: 2.345
Authors: Rafael V Monteiro; James M Dietz; Becky Raboy; Benjamin Beck; Kristel De Vleeschouwer; Kristel D Vleeschouwer; Andrew Baker; Andréia Martins; Ana Maria Jansen Journal: Parasitol Res Date: 2007-08-04 Impact factor: 2.289
Authors: E C Sabino; A L Ribeiro; T H Lee; C L Oliveira; A B Carneiro-Proietti; A P Antunes; M M Menezes; B M Ianni; V M Salemi; L Nastari; F Fernandes; V Sachdev; D M Carrick; X Deng; D Wright; T T Gonçalez; E L Murphy; B Custer; M P Busch Journal: Eur J Heart Fail Date: 2015-02-10 Impact factor: 15.534
Authors: Alicia I Hidron; Robert H Gilman; Juan Justiniano; Anna J Blackstock; Carlos Lafuente; Walter Selum; Martiza Calderon; Manuela Verastegui; Lisbeth Ferrufino; Eduardo Valencia; Jeffrey A Tornheim; Seth O'Neal; Robert Comer; Gerson Galdos-Cardenas; Caryn Bern Journal: PLoS Negl Trop Dis Date: 2010-05-18
Authors: Ester C Sabino; Antonio L Ribeiro; Vera M C Salemi; Claudia Di Lorenzo Oliveira; Andre P Antunes; Marcia M Menezes; Barbara M Ianni; Luciano Nastari; Fabio Fernandes; Giuseppina M Patavino; Vandana Sachdev; Ligia Capuani; Cesar de Almeida-Neto; Danielle M Carrick; David Wright; Katherine Kavounis; Thelma T Goncalez; Anna Barbara Carneiro-Proietti; Brian Custer; Michael P Busch; Edward L Murphy Journal: Circulation Date: 2013-02-07 Impact factor: 29.690
Authors: Maria Carmo P Nunes; Lewis F Buss; Antonio Luiz P Ribeiro; Ester Cerdeira Sabino; Jose Luiz P Silva; Larissa Natany A Martins; Claudia Di Lorenzo Oliveira; Clareci Silva Cardoso; Bruno Oliveira de Figueiredo Brito; Ariela Mota Ferreira; Lea Campos Oliveira; Ana Luiza Bierrenbach; Fabio Fernandes; Michael P Busch; Viviane Tiemi Hotta; Luiz Mario Baptista Martinelli; Maria Carolina F Almeida Soeiro; Adriana Brentegani; Vera M C Salemi; Marcia M Menezes Journal: Circulation Date: 2021-09-27 Impact factor: 29.690
Authors: Jacqueline E Sherbuk; Emi E Okamoto; Morgan A Marks; Enzo Fortuny; Eva H Clark; Gerson Galdos-Cardenas; Angel Vasquez-Villar; Antonio B Fernandez; Thomas C Crawford; Rose Q Do; Jorge Luis Flores-Franco; Rony Colanzi; Robert H Gilman; Caryn Bern Journal: Glob Heart Date: 2015-09
Authors: Angel G Guevara; Richard D Atherton; Michael A Wauters; Yosselin Vicuña; Marcos Nelson; Jose Prado; Hirotomo Kato; Manuel H Calvopiña; Yoshihisa Hashiguchi Journal: Trop Med Health Date: 2013-02-14